{"title": "Administration | AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted)", "author": null, "url": "https://arexvyhcp.com/administration/", "hostname": "arexvyhcp.com", "description": "Find detailed instructions for administering and storing AREXVY. Watch the video and follow the step-by-step guide for proper administration.", "sitename": "arexvyhcp.com", "date": "2023-06-13", "cleaned_text": "Reconstitution and Administration Audio Welcome, this video will walk you through the reconstitution and administration process for AREXVY. On Screen Text How Supplied; Preparation Reconstitution and Administration Audio Important information about how AREXVY is supplied will also be discussed. On Screen Text How Supplied AREXVY 0.5 mL IM Injection 1. Adjuvant suspension component (liquid) 2. Lyophilized antigen component (powder) Reconstitution and Administration Audio AREXVY is supplied in 2 vials, an adjuvant suspension component (liquid) and a lyophilized antigen component (powder), that must be combined prior to administration. Use only the supplied adjuvant suspension component for reconstitution. On Screen Text How Supplied Refrigerated Between 2-8\u00b0C (36-46\u00b0F) Protect From Light Do Not Freeze Reconstitution and Administration Audio Prior to reconstitution, store both the adjuvant suspension component vials and the lyophilized antigen component vials refrigerated between 2 degrees Celsius and 8 degrees Celsius (36 to 46 degrees Fahrenheit). Store in the original package in order to protect vials from light. Do not freeze. Discard if the adjuvant suspension component or the antigen component have been frozen. On Screen Text Preparation Reconstitution and Administration Audio When you are ready to reconstitute the vaccine, follow these steps. On Screen Text Preparation Step A: Withdraw the entire contents of the vial containing the adjuvant suspension component (liquid). Step B: Slowly transfer the entire contents of the syringe into the lyophilized antigen component vial (powder). Step C: Gently swirl the vial until the powder is completely dissolved. Do not shake vigorously. Wash your hands or wear gloves. Preparation will also require needles, syringes, disinfecting swabs, and a bandage. DO NOT SHAKE VIGOROUSLY Reconstitution and Administration Audio Check the expiration date of both vials. If expired, do not use. Cleanse both vial stoppers with a sterile alcohol swab. Using sterile needles and sterile syringes, withdraw the entire contents of the vial containing the adjuvant suspension component (liquid) by slightly tilting the vial. Slowly transfer the entire contents of the syringe into the lyophilized antigen component vial (powder). Gently swirl the vial until the powder is completely dissolved. Do not shake vigorously. The reconstituted vaccine should be an opalescent, colorless to pale brownish liquid. On Screen Text Preparation Refrigerated Between 2-8\u00b0C (36-46\u00b0F) or at Room Temperature up to 25\u00b0C (77\u00b0F) Protect From Light Discard Reconstituted Vaccine if Not Used Within 4 Hours Do Not Freeze Reconstitution and Administration Audio After reconstitution, administer AREXVY immediately or store protected from light in the refrigerator between 2 degrees Celsius and 8 degrees Celsius (36 to 46 degrees Fahrenheit) or at room temperature up to 25 degrees Celsius (77 degrees Fahrenheit) and use within 4 hours. Discard reconstituted vaccine if not used within 4 hours. Do not freeze. Discard if the vaccine has been frozen. On Screen Text Preparation Prior to administration, inspect for particulate matter and discoloration Questions about AREXVY? Call 877-AREXVY1 (877-273-9891) Reconstitution and Administration Audio Immediately prior to administering, parenteral drug products should be inspected visually for particulate matter and discoloration immediately prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered. On Screen Text Preparation STEP D: After reconstitution, withdraw 0.5 mL from the vial containing the reconstituted vaccine and administer intramuscularly. AREXVY is for intramuscular injection only For illustrative purposes only. Reconstitution and Administration Audio After reconstitution, if stored, cleanse the vial stopper with a sterile alcohol swab prior to administration. Withdraw 0.5 mL from the vial containing the reconstituted vaccine. Disinfect the injection site prior to administration, and administer intramuscularly. AREXVY is for intramuscular injection only. On Screen Text GSK Logo Trademarks are owned by or licensed to the GSK group of companies. \u00a92023 GSK or "}